BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
3.230
-0.130 (-3.87%)
At close: Jun 5, 2026, 4:00 PM EDT
3.210
-0.020 (-0.62%)
After-hours: Jun 5, 2026, 5:04 PM EDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $14.26 million as of June 5, 2026. Its market cap has increased by 15.32% in one year.
Market Cap
14.26M
Enterprise Value
9.84M
1-Year Change
15.32%
Ranking
Category
Stock Price
$3.23
Market Cap Chart
Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $14.26M, a decrease of -57.80%. That is a compound annual growth rate of -4.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 14.26M | 8.86% |
| Dec 31, 2025 | 13.10M | -44.21% |
| Dec 31, 2024 | 23.49M | -79.62% |
| Dec 31, 2023 | 115.26M | 305.33% |
| Dec 29, 2022 | 28.44M | -71.41% |
| Dec 30, 2021 | 99.46M | 66.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoMed Therapeutics | 13.96M |
| Jasper Therapeutics | 13.47M |
| Moleculin Biotech | 13.39M |
| CalciMedica | 13.39M |
| Cadrenal Therapeutics | 13.27M |
| Phio Pharmaceuticals | 13.24M |
| Lunai Bioworks | 13.24M |
| Cyclerion Therapeutics | 12.98M |